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Abstract 
 Background: Atherosclerosis is an arterial inflammation that causes ischemic 
heart disease, which is the first leading cause of death worldwide. Macrophages play 
major roles during disease development by having pro-inflammatory and anti-
inflammatory functions. Lack of effective treatment is mainly due to incomplete 
understanding of the molecular mechanisms underlying disease progression and 
regression. 
 Materials and methods: The transcripts of the macrophages from two aortic 
samples from atherosclerotic region during disease progression and regression were 
analyzed using previously published dataset (GEO Accession GSE123587). Pre-
processing, clustering of cells and identification of unique markers for each cluster 
were done using Seurat package implemented in R programming language. Monocle 
package was used to order the cells in pseudotime and to detect the key molecules that 
changed dramatically during comparison between distinct macrophages states (pro-
inflammatory and anti-inflammatory). Ingenuity Pathway Analysis (IPA) software 
was used to analyze the pathways activity across macrophage states along the 
trajectory and to retrieve the transcriptional regulatory network between the genes 
determining the final states. Prediction of the miRNAs that might be involved in the 
disease progression was performed using TargetScan and GSEA (Gene Set 
Enrichment Analysis). Cytoscape application was used to visualize the regulatory 
network between the differentially regulated genes across macrophages states.  
 Results: Clustering analysis of macrophages revealed their presence in 
distinct 11 states. In addition, Two states were found to be dominant in the 
progression group macrophages, and one state was found to be dominant in the 
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regression group macrophages. Moreover, trajectory analysis showed a bifurcation 
point near the end of the trajectory, where macrophages fates were destined to be 
either pro-inflammatory or anti-inflammatory.  Macrophages unique to the disease 
progression branch were found to activate STAT cascade, induce acute inflammatory 
response and upregulate inflammatory cytokines, denoting M1 polarization. In 
contrast, regression-branch specific macrophages were found to activate cholesterol 
efflux pathways and upregulate anti-inflammatory cytokines such as TSLP and 
CCL24. The transcription regulatory network between differentially regulated genes 
in both branches revealed changes in the transcriptional dynamics acquired during 
macrophage states transition. STAT1 (Signal transducer and activator of transcription 
1) and IRF7 (Interferon Regulatory Factor 7) were found to be upregulated in the 
progression branch to maintain an inflammatory module resulting in production of 
distinct inflammatory cytokines. On the other hand, MAFB (MAF BZIP Transcription 
Factor B) and IGF1 (Insulin-like growth factor 1) were found to be upregulated in the 
regression branch to interrupt the inflammatory module at different levels. In addition, 
10 miRNAs were predicted to be unregulated in progression-branch specific 
macrophages such as miR-344, miR-346 and miR-485.   
 Conclusion: Inflammatory sites in atherosclerosis lesions contain both pro-
inflammatory and anti-inflammatory macrophages. Each subset of macrophage 
activates unique transcriptional program. Certain transcription factors and growth 
factors have potential to alter the whole transcriptional regulatory network, thereby 
shifting the macrophages from inflammatory to anti-inflammatory state. 
Understanding how macrophage state transition occurs from inflammatory to anti-
inflammatory state will be a key step to better understanding and treating 
atherosclerosis.  
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CHAPTER 1: Introduction 
1.1 Atherosclerosis 
 1.1.1 Epidemiology and Statistics 
 Atherosclerosis is a chronic inflammation of the arteries, which is initiated by 
low density lipoprotein (LDL) accumulation in defined regions in the arteries where 
the blood flow is disturbed and non-laminar. Atherosclerosis results in stroke, heart 
attacks and peripheral arterial disease (Dichgans M et al., 2019; Mohd Nor NS et al., 
2019; Paul S et al., 2019). It is the major cause of cardiovascular diseases resulting in 
ischemic heart disease and ischemic stroke, which are the first and fifth causes of 
death worldwide; respectively (Ala-Korpela M et al., 2019; Watson M et al., 2019; 
Whelton SP et al., 2019; Carmona FD et al., 2019). 
 1.1.2 Aetiology and Pathophysiology 
 Multiple risk factors are involved in the development of atherosclerosis. The 
most common factors include elevated blood LDL (hypercholesterolaemia), diabetes 
mellitus, hypertension, smoking, sex as a male, old age (more than 45 years for males 
and more than 55 years for females) and family history of the disease (Reiss AB et 
al., 2019; Shafi S et al., 2019; Doodnauth SA et al., 2019). Atherosclerosis 
development started with endothelial cells dysfunction and infiltration of immune 
cells in the lesion micro-environment, resulting from arterial wall injury (figure 1).   
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Figure 1. Atherosclerosis resulting from chronic arterial wall injury. Chronic 
inflammation of endothelial cells resulting from atherosclerotic risk factors induces 
endothelial cells dysfunction and alteres the arterial wall micro-environment. 
Macrophages recruitment to the lesion site results in foam cell formation after 
engulfing the deposited lipids in the arterial wall intima. Reproduced with permission 
(Rafieian-Kopaei et al., 2014). Image Source Reference; Copyright; see appendix. 
 
 
 Atherosclerosis is a continuous process of arterial wall lesions caused by lipid 
retention in the intimal part of the artery, which results in aggravation of the chronic 
inflammation. Following lipid retention, the intima develops fibrous plaques, 
resulting in disease complications such as stenosis or remote vessel occlusion due to 
rupture of the fibrotic plaque. Mechanisms of plaque rupture include shear stress 
injury (Gertz S et al., 1990), transient collapse of the stenotic lesion (Binns R et al., 
1989) mechanical shear injury (Vito R et al., 1990) and vasa vasorum rupture (Barger 
A et al., 1991). 
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1.1.3 Immune Cells in Atherosclerotic Plaques 
 Atherosclerotic plaques contain several immune cells, including dendritic 
cells, macrophages and platelets (Libby et al., 2013). Dendritic cells have been found 
to increase dramatically as the disease progresses in the atherosclerotic plaques 
(Galkina E et al., 2006). They produce distinct chemokines in the lesion area resulting 
in recruiting lymphocytes and monocytes to the inflammation micro-environment 
(Huang DR, et al., 2001). 
 Macrophages in the plaque sites originate either from recruitment of blood 
circulating monocytes or from proliferation of tissue resident macrophages (Ginhoux 
and Jung, 2014). Macrophages have been found to play dual roles in the development 
of atherosclerosis as both of the phenotypes (M1 and M2) were found in 
atherosclerotic plaques (figure 2, 3) (Bouhlel et al., 2007 , De Paoli et al., 2014). 
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Figure 2. Distinct phenotypes of macrophages during atherosclerotic plaque 
development. During early stages of the disease development, activation of 
endothelial cells occur. Following endothelial cells activation, monocytes are 
recruited into the lesion micro-environment and differentiated into macrophages. 
Distinct states of macrophages are found in the lesion site playing either 
inflammatory (M1 phenotype) or anti-inflammatory (M2 phenotype) roles. 
(Reproduced with permission (Sai Yang et al., 2019). Image Source Reference; 
Copyright; see appendix. 
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Figure 3. Macrophages phenotypes M1 and M2 roles during inflammation and 
resolution. M1 phenotype is present during early stages of inflammation having roles 
in inducing inflammatory response. On the other hand, M2 phenotype is present 
during late stages of inflammation inducing resolution of the inflammatory response. 
Reproduced with permission (Amitava Das et al., 2015). Image Source Reference; 
Copyright; see appendix. 
 
 
 Pro-inflammatory (M1) macrophages have been found during plaque growth 
causing inflammation. They ingest lipid particles and form foam cells where their 
cytoplasm is filled with lipid droplets. Those foam cells secrete various signalling 
molecules and pro-inflammatory cytokines to further recruit monocytes, cause more 
lipid retention and result in extracellular matrix remodelling (Libby, 2002; Orekhov et 
al., 2014). On the other hand, anti-inflammatory macrophages (M2) have been found 
in the lesion area causing plaque regression and inflammation resolution (Nathan and 
Ding, 2010). Furthermore, M2 phenotype cells are more resistant to form foam cells 
and they contain fewer lipid droplets, indicating distinct metabolic activity between 
both phenotypes (Chinetti-Gbaguidi et al., 2011). 
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 1.1.4 Integrin Signalling in Atherosclerotic Plaque Development 
 Distinct subsets of integrins have been found to be expressed by leukocytes 
and white blood cells to mediate their interaction with the endothelial surface markers 
(Hynes RO., 2002). These integrins have roles in the initial targeting leukocytes to 
the inflammation site, facilitating their migration along endothelial cells into the 
neointimal matrix (Ley K, et al., 2007) and regulation of their function upon 
transendothelial migration into the inflammation micro-environment (Libby P et al., 
2015). Initial weak bonds are formed between integrins expressed by leukocytes and 
selectins present on the endothelial cell surface. Notably, Atherosclerotic plaque 
formation reduces dramatically following selectins deletion (Collins RG et al., 2000; 
Dong ZM et al., 2000). Following integrins activation, leukocytes make rolling 
movements resulting in firm cell adhesion and chemokines arrest on the endothelial 
surface (Shamri R et al., 2005). The resulting increase in chemokines induces 
inflammation and aid in further recruiting of more leukocytes (Boring L et al., 1998). 
 1.1.5 Cytokines and Their Role in Atherosclerosis Development 
 Cytokines are low-molecular weight proteins that are clustered into several 
groups as interleukins, tumour necrosis factors, interferons (IFN), transforming 
growth factors, chemokines and colony-stimulating factors. They are expressed in the 
atherosclerotic plaques by almost all the cells in the lesion micro-environment having 
either pro-inflammatory or anti-inflammatory role (Kleemann R et al., 2008; 
McLaren J.E et al., 2011; Ait-Oufella H et al., 2011). Cytokines and chemokines are 
potent signaling molecules mediating intercellular communication (Dinarello, 2007). 
During initial stages of the disease development, cytokines have a role in modulating 
endothelial cells permeability resulting in activating and opening up gaps between 
cells (Pober J.S. et al., 2007). The activated endothelial cells release chemokines 
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(chemoattractant cytokines) causing further recruitment of circulating leukocytes 
especially monocytes and T cells (McLaren J.E. et al., 2011). Chemoattractant 
chemokines modulate diverse intra-signalling pathways upon interaction with cell 
surface receptors involving activation of G proteins (Koenen R et al., 2010; Weber C 
et al., 2011). 
 1.1.5 Treatment and Management 
 Management of atherosclerosis is mainly by treating the risk factors as 
elevated blood LDL, diabetes and others. Patients are advised to eat healthy diet 
containing low saturated fat and less salts. In addition, they are encouraged to 
exercise 90 to 150 minutes per day. Furthermore, drugs such as statins are used to 
lower LDL cholesterol and reduce complications. Statins are a group of cholesterol-
lowering compounds which act by inhibiting Hydroxymethylglutaryl Coenzyme A 
Reductase (HMG-CoA). This inhibition reduces the rate by which the enzyme is able 
to produce mevalonate, which is a major molecule in the cascade that produces 
cholesterol (Endo A, 1992). Although statins can lower blood cholesterol level, they 
have side effects such as muscle pain and abnormal blood levels of liver enzymes 
(Abd TT et al., 2011). In severe stenosis, surgical intervention is recommended such 
as coronary artery bypass grafting (Perez-Martinez P et al., 2019; Spannella F et al., 
2019; Esper RJ et al., 2019; Arnett DK et al., 2019). The complicated roles of 
macrophages in atherosclerotic plaque micro-environment is poorly understood. 
Thus, better understanding of the molecular alterations caused by macrophages in the 
atherosclerotic plaque site is needed for improving the disease treatment. 
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 1.2 Reverse Cholesterol Transport in Macrophages 
 Reverse cholesterol transport (RCT) was first described by Glomset (Glomset 
JA, 1968) as the process of returning the excess circulatory cholesterol to liver.  RCT 
relationship with atherosclerosis development was first hypothesized as an imbalance 
which occurs between arterial cholesterol deposition and removal (Ross R & Glomset 
JA, 1973). In atherosclerotic plaques, macrophages are the primary cell type that are 
overloaded with cholesterol (Tall AR, 2001). Macrophages take up the dead cells that 
contain much cholesterol, lipoproteins and cellular debris (Rader DJ, 2005). The 
unesterified cholesterol has toxicity effect on macrophages leading to apoptosis (abas 
I, 2004). Thus, esterification of cholesterol to cholesteryl ester (CE) is the first line of 
defense against cholesterol toxicity in macrophages by the enzyme ACAT1 
(acyl:coenzyme A cholesterol O-acyltransferase-1) (Chang TY, 2001). Cholesterol 
ester is stored in the cytoplasm and its accumulation results in foam cell formation.  
 The second line of defence against cholesterol toxicity is the cholesterol 
efflux. ABCA1 is an active cholesterol efflux pathway and its knock out in mice 
results in development of accelerated atherosclerosis (Aiello RJ, 2002). However, 
alternative pathways by which macrophages can be able to induce cholesterol efflux 
exist. ABCG1 was identified to promote cholesterol efflux in the form of HDL 
particles and its knock out results in intracellular lipid accumulation (Kennedy MA, 
2005). Both ABCA1 and ABCG1 are regulated by the nuclear receptors liver X 
receptor LXR-α and LXR-β (Tontonoz P, 2003). Excess intracellular cholesterol 
induces formation of oxysterol which are the ligands for liver X receptors (Repa JJ, 
2002). Thus, excess cholesterol upregulates major pathways for cholesterol efflux 
through ABCA1 and ABCG1 to protect the cells from the toxicity. Moreover, mice 
deficient in LXR-α/-β have been found to have lipid accumulation within 
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macrophages and tissues and have advanced atherosclerosis (Tangirala RK, 2002). 
Furthermore, peroxisome proliferator–activated receptor PPAR-α and PPAR-γ 
agonists were found to induce cholesterol efflux from macrophages through 
upregulation of LXRs (Chinetti G, 2001 ; Li AC, 2004; Chawla A, 2001). Following 
unesterified cholesterol efflux from macrophages, it associates with plasma HDL. 
Then, lecithin:cholesterol acyltransferase (LCAT) catalyzes its esterification to 
cholesteryl ester (CE) (Fielding CJ, 1995). As CE is hydrophobic, it moves to the 
lipoprotein particle core allowing mature HDL formation. LCAT-deficient mice were 
found to have very low level of HDL (Rader DJ, 1994) and its overexpression 
resulted in high HDL level and reduction in atherosclerosis (Hoeg JM, 1996). 
 1.3 Macrophages plasticity and polarization 
 Macrophages are plastic cells which can switch their state from one phenotype 
to another (Mantovani et al., 2004; Sica & Mantovani, 2012). Polarization of 
macrophages is a process in which macrophages change their transcriptional program 
in response to stimuli and signals from the surrounding micro-environment (Sica & 
Mantovani, 2012). Several classes of macrophages have been described based on 
their metabolic activity, surface markers expression and their released molecules. The 
two major sub-populations with opposing functions are M1 phenotype 
(inflammatory) and M2 phenotype (anti-inflammatory). The phenomenon of 
macrophages can change their state from M1 to M2 and the opposite is referred to 
term “macrophage polarization” (Cassetta, Cassol & Poli, 2011; Chittezhath et al., 
2012).  
 M1 macrophages are induced by Th1 cytokines (IFN‐γ and TNF‐α) and they 
produce pro-inflammatory cytokines such as TNFα, IL1α, IL1β and IL6 (Biswas et 
al., 2012 ; Bashir et al., 2016). On the other hand, M2 macrophages are induced by 
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Th2 cytokines (Wang et al., 2014) and have anti-inflammatory roles. However, the 
M1/M2 phenotype does not reflect the distinct subsets of macrophages. They can be 
further subdivided into different sub-types (Chistiakov et al., 2015). Recent advances 
in single cell RNA-sequencing enables identification of phenotypes not previously 
identified (Hannah Van Hove et al., 2019; Jian-Da Lin et al., 2019). 
 1.4 miRNA in Atherosclerosis 
 miRNAs are small non-coding RNAs, ~22 nucleotides in length. Biogenesis 
of miRNAs starts with processing of RNA polymerase II/III transcripts mostly from 
introns and few from exons and intergenic regions (Ha M et al., 2014; de Rie D et al., 
2017). miRNAs biogenesis is classified into canonical and non-canonical pathways. 
The canonical biogenesis pathway is the dominant pathway in which the pri-miRNAs 
are transcribed and processed into pre-miRNAs. Processing of pre-miRNAs are 
performed by the microprocessor complex (DGCR8 , RNA binding protein DiGeorge 
Syndrome Critical Region 8 and Dorsha, a ribonuclease III enzyme) (Denli AM et al., 
2004).  DGCR8 recognizes motifs within the pre-miRNA (Alarcón CR et al. 2015)  
and Drosha cleaves the pri-miRNA resulting in formation of a 2 nt 3′ overhang on 
pre-miRNA (Han J et al., 2004).  Then, the pre-miRNA is exported to the cytoplasm 
by exportin 5 (XPO5)/RanGTP complex and further processed by the RNase III 
endonuclease Dicer resulting in formation of the mature miRNA (Okada C et al., 
2009). In addition, multiple non-canonical miRNA biogenesis pathways have been 
discovered. They can be classified into Drosha/DGCR8-independent and Dicer-
independent pathways.  
 miRNAs recognize and bind  to the 3′ UTR of the target mRNAs inducing 
translational repression and mRNA deadenylation and decapping (Huntzinger E et al., 
2011). They have roles in both production and clearance of lipoproteins. miR-122 is 
 11 
 
the first identified miRNA to have a role in lipoprotein metabolism (Esau C et al., 
2006). Furthermore, overexpression of miR-30 in mice resulted in hyperlipidaemia 
and atherosclerosis development (Soh J et al., 2013). Other miRNAs have been 
identified to alter cholesterol efflux by targeting ABCA1 including miR-33 (Gerin I et 
al., 2010), miR-758 (Ramirez CM et al., 2011), miR-144 (De Aguiar Vallim TQ et 
al., 2013). Thus, miRNAs have potential roles in atherosclerosis progression and 
regression. 
 1.5 Single Cell RNA Sequencing 
 Cells express different transcriptional programs while being in different states 
even in similar cell types (Huang S et al., 2009; Li L et al., 2010; Shalek A K et al., 
2014). The transient states in-between stable states are difficult to be detected using 
traditional experimental methods such as bulk RNA sequencing. Fortunately, single 
cell RNA Sequencing allows detection of cells in those transition states without the 
needs of their purification. It enables studying the heterogeneity among similar 
cellular populations (Montoro DT et al., 2018; Plasschaert LW et al., 2018). 
 Multiple steps are required to generate single-cell data from a biological 
sample and different protocols can be used. Generally, the steps incorporate 
dissociation of single cells, library constructions and sequencing (Vieth B et al., 2017; 
Macosko EZ et al., 2015; Rostom R et al., 2017). Droplet-based methods such as 10x 
Genomics (which was used in the original study) start with isolating each cell from 
the sample and capturing it in a microfluidic droplet. Although multiple cells or 
cellular debris can be captured within the same droplet, computational methods can 
be applied to overcome this issue by detecting and excluding those cells. Each droplet 
contains the necessary enzymes and chemicals to digest the cell membrane and 
perform library construction by reverse transcription of mRNAs generated from the 
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single cell. Additionally, each droplet contains a barcode of 16 nucleotide long which 
labels all the mRNAs from this single cell. After library construction, all the cDNAs 
from each single cell are labelled with a unique barcode and the libraries are pooled 
together for sequencing.  
 1.6 Pseudotime 
 Pseudotime is an abstract unit of measurement as it measures how much 
progress for each individual cell has been made through the process of state transition 
between cells. For the macrophages in atherosclerotic plaque, they were found to be 
in different states (Bouhlel et al., 2007; De Paoli et al., 2014). Monocle package in R 
uses reversed graph embedding algorithm to learn the sequence of change in gene 
expression each cell must go through across dynamic biological processes in single 
cells experiments (Qi Mao et al., 2016; Xiaojie Qiu et al., 2017). Thus, it enables 
constructing a pseudo-temporal path to order the cells based on the gradual 
continuous change of their transcriptomes (Trapnell C et al., 2014; Haghverdi L et al., 
2016). 
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CHAPTER 2: Hypothesis and Objectives 
2.1 Hypothesis 
 Macrophages play a vital role in atherosclerosis during progression and 
regression phases of the disease. They are able to dramatically change their states 
between pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes. This results 
in secretion of distinct set of cytokines and activation of different metabolic 
programs, which affect their ability to digest the lipid particles in the inflammatory 
micro-environment. 
 Therefore, it is hypothesized that using single cell RNA sequencing help in 
identifying the molecular signature of the macrophages during disease progression 
and regression, the change in pathways activity during macrophages transition across 
different states and the key molecules which drive the transition decision for the 
macrophages to be either in an inflammatory (M1) or an anti-inflammatory (M2)  
state. 
2.2 Objectives 
1. To cluster macrophages from each sample into distinct states (11 states). 
2. To detect the macrophages states unique to disease progression (2 states) or 
regression (1 state). 
3. To order the cells in pseudotime to detect the bifurcation points where 
macrophages go through different fates. 
4. To calculate the pathways activity in different fates across the pseudotime. 
5. To identify the key genes that drive the macrophages to either state. 
6. To predict the miRNAs that may be involved in states transition. 
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CHAPTER 3: Materials and Methods 
3.1 Data source 
 The data was obtained from the GEO (http://www.ncbi.nlm.nih.gov/geo) 
under the accession number GSE123587. The data was produced by Jian-Da Lin et al, 
a research group in USA in 2019 (Jian-Da Lin et al., 2019). Their paper is entitled 
“Single-cell analysis of fatted-mapped macrophages reveals heterogeneity, including 
stem-like properties, during atherosclerosis progression and regression”. The paper 
was published in JCI Insight Journal, Volume 8, Issue 8, 2019. The original study 
aimed to address the differentiation of CX3CR1+ CCR2+ cells into macrophages in 
atherosclerotic plaques during progression and regression of the disease.  
 The authors generated a chimeras of LDLr-/- (LDL receptor) mice and placed 
all the eight weeks old mice onto a Western diet (contains high fat content) for 18 
weeks. Then, the mice were divided into two groups: a progression group which 
continued on Western diet and a regression group which was switched to a chow diet 
(less fat) and injected with apolipoprotein B (ApoB) anti-sense oligonucleotide 
intraperitoneal (50mg/kg) twice per week to lower the atherogenic lipoproteins. After 
2 weeks, they sorted the macrophages from the aortic arches of progression and 
regression groups. This enabled excluding cells from lymphoid lineage such as T 
cells, B cells, eosinophils, neutrophils and natural killer cells.  
 Then, the sorted cells were processed to single-cell RNA sequencing. Finally, 
by combining four samples from each group with total number of 10,000 to 12,000 
cells for each group, cells were loaded on 10x Genomics instrument and libraries 
were prepared as described (GX et al., 2017). Then, the authors used CellRanger 
Single Cell Software Suite (version 1.3) for processing the raw reads and generating 
 15 
 
the count matrix (https://support.10xgenomics.com/single-cell-gene-
expression/software/pipelines/latest/what-is-cell-ranger). 
3.2 Single Cell RNA-Seq Counts Matrix Pre-processing 
 The generated count matrix from the two samples was used to perform quality 
check and further downstream analysis. Seurat package in R (v3.1.0) was used to 
process the counts matrix, barcodes and genes for each sample (Stuart T et al., 2018; 
Butler et al., 2018). 
 3.2.1 Data Integration 
 The data from the two samples was integrated to enable the identification of 
common cellular states and to allow comparative analysis between them as described 
in Butler et al., 2018. Briefly, integration of the two samples required multiple steps 
starting from data normalization to identification and integration of anchors between 
cells from the two samples. For normalization, log 10-transformation of expression 
values for each gene was performed, using 10,000 molecules for each cell as a size 
factor. Then, standardization of expression value of each gene across all the cells was 
performed (linear transformation) to shift the expression of each gene, so that the 
mean is 0 and the variance is 1 across all the cells. This gives equal weight, so that no 
domination for the highly expressed genes in the downstream analysis.  
 The top 2000 highly variable genes in both samples were chosen to perform 
canonical correlational analysis (CCA) and dimensionality reduction to detect cells 
from the 2 samples with common biological states. K-nearest neighbours (KNNs) 
were identified and each pair of cells from the two samples represent an anchor 
(mutual nearest neighbours). Further filtering of anchors was performed by giving a 
score to each anchor using shared nearest neighbour (SNNs) graphs between the two 
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samples. Finally, small number of anchors surrounding each cell were considered for 
identifying the integration anchors. The identified anchors and the weights matrix was 
used to integrate the two samples as described in Haghverdi L et al., 2018. 
 3.2.2 Filtering low quality cells 
 As suggested before, there is a positive correlation between expression level 
of mitochondrial encoded genes and cell death (Detmer SA et al., 2007; Galluzzi L et 
al., 2012, Silvia Márquez-Jurado et al., 2018). Thus, cells that exhibit mitochondrial 
contamination (more than 5% of the reads are mitochondrial encoded genes) were 
filtered. Also, cells with very high or very low total number of gene counts (more 
than 7000 or less than 2500) were filtered as high counts may represent cell doublets 
or multiplets and low counts may represent empty droplets or represent premature cell 
rupture leading to mRNA leakage.  
 Moreover, cells identified as non-macrophages were excluded from the 
analysis. Identification of each cell type was performed using SingleR package 
implemented in R (Aran D et al., 2019). The algorithm computes the similarity 
between the dataset and a reference dataset for unbiased recognition of cell types. The 
reference dataset chosen was ImmGen (Immunological Genome Project), which 
includes 830 microarrays classified into 20 main cell types and 253 subtypes. Briefly, 
Spearman coefficient was calculated for each cell expression with each of the 
reference datasets samples. Then, correlation analysis was performed followed by 
aggregation of multiple correlation coefficients per cell types using 80% percentile of 
the correlation values. Next, the correlation analysis was rerun using only the top cell 
lines resulted from the previous step and the variable genes between those cell types, 
while removing the lowest cell type. Finally, the previous step was repeated until two 
cell types remained and the top one was assigned to the cell. 
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 3.2.3 Dimensionality Reduction 
 Principal component analysis (PCA) was performed using the previously 
identified 2000 highly variable genes in both samples. Each principal component 
represents information about a correlated gene set. To further determine how many 
principal components to be used for dimensionality reduction, Jackstraw procedure 
was used (Chung NC et al., 2015). Jackstraw procedure is a resampling test, in which 
a subset of the data is randomly permuted and PCA is rerun, allowing for construction 
of a “null distribution” of genes scores. This method allows identification of the 
significant PCs that have low p-values. In addition, a heuristic method based on the 
percentage of variance represented by each gene was used to generate elbow plot. 
Consequently, the first 24 principal components were chosen to reduce the data 
dimensions for downstream analysis to enable using the highly variable genes instead 
of using all the genes as features. 
3.3 Clustering of Single Cells 
 A graph-based clustering approach was used for clustering the cells. Cells 
were embedded in a graph structure (KNN graph) based on Euclidean distance in 
PCA space. Then, edge weights were refined between any pair of cells based on 
Jaccard similarity (the shared overlap between the cells local neighbourhoods). Edge 
refinement was performed using the first 24 PCs as previously determined to be the 
dimensionality of the data. After refinement edge weights, edges were drawn between 
cells having similar gene expression patterns. Louvain algorithm was applied as a 
modularity optimization technique to group cells together. Finally, Uniform Manifold 
Approximation and Projection (UMAP) was used to visualize the cells using the 
reduced dimensions (Becht et al., 2018; McInnes et al., 2018). 
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3.4 Identification of Unique Markers for Each Cluster 
 To identify unique markers for each cluster, Seurat was used to perform 
differential expression analysis by comparing each cluster with the rest of other 
clusters using Wilcoxon Rank-Sum Test. Log2 fold change cut off value of ± 0.5 and 
an adjusted p value less than 0.05 were used to detect the differentially expressed 
genes within each cluster. 
3.5 Constructing Single Cell Trajectories 
 Monocle package in R (v2.10.1) uses reversed graph embedding algorithms to 
order the cells in pseudotime and construct the trajectory (Trapnell C et al., 2014). 
The significant markers from all the clusters with log2 fold change ± 0.5 were used to 
order the cells (437 genes). Briefly, the ordering algorithm reduces the data 
dimensionality, learns the smooth manifold that generates the data and finally places 
every cell at the proper position in the trajectory through unsupervised method. In 
addition, if there are multiple outcomes, it reconstructs a branched tree representing 
different cellular fates (Qi Mao et al., 2015). 
3.6 Differential Expression Analysis of the Terminal Branches 
 Furthermore, Monocle enables detection of branch points along the trajectory. 
The significant branch-dependent genes are the genes that explicit different 
expression dynamics along each branch. Branched expression analysis modelling 
(BEAM) algorithm implemented in Monocle, was used to find all the genes that 
differ between the two terminal branches after the bifurcation point. Then, 
hierarchical clustering of the resulting top 457 genes with (q value less than 1e10-4) 
was performed for further downstream analysis. Finally, EnrichR 
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(https://amp.pharm.mssm.edu/Enrichr/) was used to enrich the identified clusters with 
the significant gene ontology biological processes (Maxim V et al., 2016). 
3.7 Pathway Activity Analysis 
 Pathway activity analysis was performed using Ingenuity Pathway Analysis 
software (IPA) (QIAGEN Inc., 
https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis). The 
algorithm considers the role of each gene within the pathway, so that each pathway 
has a pattern to be considered fully activated. If the gene is consistent with its pattern 
specific to pathway i, score of 1 is assigned to the gene in pathway i, and if it is 
inconsistent, a score of -1 is assigned for this gene in pathway i. Finally, for 
determining the activity of pathway i, Z score was calculated for each pathway in 
each pseudotime point using the following equation,  where z is the activation score: 
 
 Xi is the score of a gene in the pathway. N+ and N- are the number of the 
consistent and inconsistent genes with the pathway pattern; respectively. N is the total 
number of genes in pathway i. Then, the 457 genes differentially expressed between 
the 2 branches were used with 20 pseudotime points representing the whole 
pseudotime. The gene was considered upregulated or downregulated using cut off ± 
0.5. 
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3.8 Transcription Regulatory Network Analysis 
 The genes that were identified to be differentially expressed between the two 
different fates of macrophages using BEAM algorithm (457 genes) were used to 
construct the transcriptional regulatory network. First, IPA was used to retrieve the 
experimentally validated relationships between the genes. Then, causal analysis was 
performed using IPA software to detect the subnetworks consistent with the results as 
previously described (Andreas et al., 2014). Finally, Cytoscape application was 
applied to visualize the resulting network using the values of the last pseudotime 
points from both branches (Shannon P et al., 2003). 
3.9 miRNAs Prediction 
 TargetScan (http://www.targetscan.org/) was used to predict the miRNAs 
that may play a role in regulating the expression level of the differentially regulated 
genes in progression versus regression branch. The Predicted targets of all known 
mouse miRNAs were downloaded based on their alignment with the 3’ untranslated 
regions of each transcript (Rosenbloom KR et al., 2013; Agarwal V et al., 2015). 
Then gene set enrichment analysis (GSEA) was performed using the gene 
expression data at the end of the progression branch 
(http://software.broadinstitute.org/gsea/index.jsp) (Subramanian et al., 2005).  
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CHAPTER 4: RESULTS 
 The authors in the original study performed scRNA-seq using 10x Genomics 
technology and performed the alignment using CellRanger software (Jian-Da Lin et 
al., 2019). The goal of the current study is to start from performing the quality control 
and clustering of the cells to trajectory inference, pathway activity analysis and 
miRNA prediction (Figure 4). 
 
Figure 4. The analysis workflow. Sequencing of single cells were performed using 
10x Genomics technology. CellRanger was used for mapping of reads to the mouse 
genome. Seurat package in R was used for pre-processing of the resulting count 
matrix, clustering and identification of unique markers for each cluster. Then, 
Monocle in R was used for trajectory inference and analysis of the bifurcation point. 
The resulting differentially expressed genes were used for different downstream 
analysis applications. EnrichR was used for GO biological processed enrichment of 
the resulting clusters. Ingenuity Pathway Analysis (IPA) software was used to 
analyse pathway activity over pseudotime and for retrieving the transcriptional 
regulatory network. TargetScan was used along with Gene Set Enrichment 
Analysis (GSEA) for miRNA prediction. Cytoscape was used for network 
visualization. 
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4.1 Pre-processing of Single Cell RNA Sequencing Counts Matrix 
 Data from a total number of 3157 cells for progression group and 2198 cells 
for regression group were analysed. Using SingleR package, most of the cells were 
identified as macrophages, while few number of cells were assigned to dendritic cells, 
B cells, monocytes, stem cells and stromal cells. 1565 cells during atherosclerosis 
progression and 1421 cells during atherosclerosis regression remained after excluding 
cells with mitochondrial contamination, very high or low total counts and non-
macrophages cells (figure 5; figure 7-A & B; section 3.2.2 in methods). 
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Figure 5. Quality check for single cells before and after filtering. (A) Violin plots 
showing abundance of cells in each sample regarding the number of detected genes 
(features), total number of gene counts per cell and the percentage of mitochondrial 
genes expression (left: before filtering and right: after filtering). Each dot represents 
one cell. (B & C) Scatter plots before and after filtering; respectively showing number 
of gene counts against percentage of mitochondrial genes (left) and against total 
number of detected genes per cell (right) 
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 Following log10-normalization and scaling of the gene counts, PCA was 
performed using the top 2000 variable genes from both samples. Jackstraw procedure 
was utilized to assign p value for each principal component as shown in figure 6-A. 
Moreover, elbow plot was generated using a heuristic method based on the 
percentage of variance represented by each gene as in figure 6-B. Analysis of the 
principal components suggest that the majority of the signal was captured in PCs 
from 1 to 24. 
Figure 6. Principal component analysis of single cells. (A) Jackstraw plot 
showing the first 50 principal components from the PCA analysis with their 
corresponding p-values. (B) Elbow plot showing the standard deviation of the first 50 
PCs. 
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4.2 Clustering and Visualization 
 A graph-based clustering approach was performed to cluster the cells using 
the first 24 principal components. Then, UMAP algorithm was used as a non-linear 
dimensionality reduction technique to visualize the data as shown in figure 7-C. 
Figure 7-D represents the percentage of the cells assigned to each cluster in respect to 
each condition (progression and regression groups). Clusters with more than 100 cells 
and represent more than 70% of their cells from either group were considered to be 
condition-specific clusters. Cluster four consists of 71% of its cells from the 
regression group, while 82% and 83% of clusters six and seven; respectively arose 
from the progression group (Figure 7-D, table 1). 
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Figure 7. Clustering of single cells and compositional analysis of the clusters. (A) 
t-distributed stochastic neighbor embedding (t-SNE) projection of the raw data before 
filtering (5355 cells) color-coded using a scale of gray to violet to plot the percentage 
of mitochondrial genes (right), total number of gene counts per cell (left) and number 
of unique genes per cell (middle) . Each cell is represented as a dot. (B) t-SNE plot of 
all cells showing the cells which passed the quality control (green) and the excluded 
cells (black) from the downstream analysis. (C) Uniform manifold approximation and 
projection (UMAP) projection of the filtered cells showing 11 clusters in each 
sample. (D) Compositional analysis of each cluster showing the percentage of the 
cells from each group per cluster. 
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Table 1. Number of cells assigned to each cluster in both samples 
Cluster 
number 
Number of cells Percentage 
Progression Regression Total Progression Regression 
Cluster 0 264 417 681 38.77 61.23 
Cluster 1 321 278 599 53.59 46.41 
Cluster 2 271 185 456 59.43 40.57 
Cluster 3 191 133 324 58.95 41.05 
Cluster 4 70 177 247 28.34 71.66 
Cluster 5 72 120 192 37.50 62.50 
Cluster 6 157 34 191 82.20 17.80 
Cluster 7 122 25 147 82.99 17.01 
Cluster 8 56 38 94 59.57 40.43 
Cluster 9 32 6 38 84.21 15.79 
Cluster 10 3 13 16 18.75 81.25 
 
4.3 Identification of Clusters Markers 
 Seurat was used to compare each cluster with the rest of other clusters using 
Wilcoxon Rank-Sum Test. Log2 fold change cut off value of ± 0.5 and adjusted p 
value less than 0.05 were chosen to detect unique markers for each cluster, resulting 
in a total number 437 genes for all the 11 clusters. Figure 8 represents the identified 
markers from clusters four, six and seven.  
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Figure 8. Heatmaps of the identified markers for clusters four, six and seven. (A) 
Comparison of average expression of selected markers between cluster four 
(regression-specific) and clusters six and seven (progression-specific). Markers are 
classified into cytokines, transcription factors, enzymes, peptidases, transmembrane 
proteins, transporters, phosphatases and kinases. High expression is represented by 
red color, while low expression is represented by green color. 
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4.4 Constructing and Analysis of Single Cell Trajectories 
 Monocle was used to order the cells in pseudotime and to construct the 
trajectory using the previously identified markers (figure 9-A). Branched expression 
analysis modelling (BEAM) algorithm was performed to find all the genes that differ 
between the two branches after the bifurcation point. Then, hierarchical clustering of 
the top differentially expressed genes resulted in nine clusters with distinct patterns 
across the pseudotime (Figure 9-B). Figure 9-C represents the gene ontology 
biological processes enrichment for the nine identified groups. 
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Figure 9. Single-cell trajectory analysis and dynamic changes in gene expression 
of branches-specific macrophages. (A) Cells along the trajectory are divided into 
distinct stable states and ordered according to the pseudotime development along the 
trajectory. At the branching point (highlighted with a black dot), cells divide to go 
through two fates. Cells are colored based on their position across the pseudotime 
(above) or based on the sample (below). (B) Heatmap of the top 457 differentially 
expressed genes between the two branches represents the transcriptional dynamics  
across the two branches. Genes (rows) are clustered and cells (columns) are ordered 
according to the pseudotime development. The middle part of the heatmap shows the 
pre-branch points and the outermost left and right parts show the regression and the 
progression groups; respectively. (C) The patterns of each cluster from the heatmap 
along with enrichment of the GO biological processes. All the enrichment terms have 
p-value < 0.05 and the star denotes corrected p-value < 0.25. 
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4.5 Pathway Activity Analysis 
 IPA software was used to compute pathway activity analysis for both 
branches. Figure 10-A represents a heatmap of the z scores for each pathway across 
the pseudotime in both branches. 
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Figure 10. Pathways and predicted miRNAs in macrophages across the 
pseudotime (A) Heatmap showing each pathway activity across the pseudotime for 
both the progression and regression branch-specific macrophages. The middle points 
of the heatmap represent the pre-branching pseudotime points, while the left and right 
outermost points represent the progression and regression-specific macrophages; 
respectively. (B) Gene set enrichment analysis plots for the top significant enriched 
miRNAs in the progression group. (C) The predicted upregulated miRNAs and their 
target genes. Colors represent the upregulated (red) and downregulated (green) genes 
along the trajectory in the progression branch-specific macrophages. 
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4.6 Transcriptional Regulatory Network Analysis 
 The transcriptional regulatory network was retrieved from the IPA database 
considering only the experimentally approved relationships between the differentially 
expressed genes in both branches. Causal analysis were performed using the software 
to detect the consistent subnetworks. Figure 11 B and C represent the identified 
network with gene values from the last pseudotime point from the progression and 
regression branches; respectively. 
4.7 miRNA Prediction 
 Gene set enrichment analysis (GSEA) was performed for differentially 
altered genes in both branches. The gene expression values from the last pseudotime 
point in the progression branch was used to perform the enrichment. Ten miRNAs 
were enriched with p value less than 0.05 and bonferroni corrected p value less than 
0.1 as shown in figure 10-B. 
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Figure 11. Transcriptional regulatory network showing inflammatory module in 
progression-specific macrophages (A) UMAP plotting color-coded using a scale of 
green to red to black to represent the gene expression level within each cluster (left). 
The relationship between some genes of interest (right). The transcription regulatory 
network in the last pseudotime point of progression group (B) and regression group 
(C). High expression is represented by larger node size and red color, while lower 
expression is represented by smaller size and blue color. 
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Figure 12. Expression of genes responsible for the inflammatory and anti-
inflammatory response (A) Trajectory analysis of cells within clusters four, six and 
seven. (B) Violin plots showing expression level of genes involved in maintaining the 
inflammatory module in the main network. (C) Violin plots showing expression level 
of genes involved in interrupting the inflammatory module. 
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Figure 13. Expression level of downstream targets of STAT1 and IRF7 (A) 
Violin plots showing expression level of downstream targets of IRF7 and STAT1 in 
progression-specific clusters six and seven and in regression-specific cluster four. (B) 
Subnetwork from the main transcriptional regulatory network in progression-branch 
specific macrophages (left) and in regression-specific branch macrophages (right). 
High expression is represented by larger node size and red color, while lower 
expression is represented by smaller size and blue color. 
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Figure 14. Altered downstream targets of MAFB gene MAFB and its downstream 
targets in regression-specific macrophages (A) and progession-specific macrophages 
(B). High expression is represented by larger node size and red color, while lower 
expression is represented by smaller size and blue color. 
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CHAPTER 5: DISCUSSION 
5.1 Distinct States of Macrophages During Disease Progression and Regression  
 Previous studies to evaluate the macrophage population in atherosclerosis 
demonstrated that symptomatic plaques contain macrophages of M1 inflammatory 
phenotype (Cho KY et al., 2013). In contrast, M2 anti-inflammatory phenotype was 
found to be enriched in asymptomatic lesions indicating the opposing role of 
macrophages in disease progression and resolution (Monica de Gaetano et al., 2016). 
Each phenotype stimulates distinct transcriptional program and differs regarding its 
metabolic activities. For instance, inflammatory phenotype expresses surface markers 
and secretes specific pro-inflammatory cytokines transmitting the inflammatory 
signals to neighbour cells in the plaque micro-environment. Also, their transcriptional 
state results in inefficient lipid metabolism enabling aggravating the inflammation 
and foam cell formation, while the M2 phenotype expresses certain genes enabling 
dampening the inflammation and prevention of intracellular lipid retention. 
 Clustering of macrophages from both samples resulted in identification of 11 
clusters. Although, macrophages during disease progression and regression shared 
common states, condition-specific clusters were identified. Cluster four was found to 
be more abundant in the regression group (71%), while clusters six and seven were 
abundant in the progression group, 82% and 83%; respectively, (figure 7-C, table 1). 
The two clusters (six and seven) arose mainly during atherosclerosis progression 
indicating their role in the inflammatory process. Moreover, trajectory inference 
revealed two distinct fates of macrophages, where cluster four acquired a path differs 
from that of clusters six and seven (figure 12-A). Furthermore, analysis of the 
differentially regulated genes and pathways from those unique clusters revealed new 
insights into the regulatory mechanisms underlying macrophages states during 
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disease progression and regression. For instance, the upregulated genes along the 
trajectory towards the progression branch-specific macrophages were enriched for 
biological processes that enhance the disease progress (figure 9-C). They are enriched 
for cholesterol storage, foam cell differentiation, STAT cascade, INF signalling and 
positive regulation of acute inflammatory response. On the contrary, regression 
branch-specific upregulated genes were enriched for bleb assembly and cholesterol 
efflux indicating the existence of distinct transcriptional program and metabolic 
activity for each group of macrophages. 
5.2 Extracellular Matrix Remodelling 
 Pathways activity analysis revealed increase in integrin and actin cytoskeletal 
signalling activity in the progression branch-specific macrophages while decrease in 
their activity in the regression branch-specific macrophages as shown in figure 10-A. 
Integrins are involved in the disease initiation and progression by mediating the 
interaction with endothelial cell surface receptors (Hynes RO, 2002). Although, the 
plaque extracellular matrix contains lipids and fibronectins (FN), the source of the 
fibronectins which are one of the earliest proteins deposited in the plaque site is not 
clear. Notably, deletion of FN alleles from mice significantly reduced the plaque size 
and prevent formation of the fibrous cap which results in the disease complications. 
(Ina Rohwedder et al., 2012).  
 Interestingly, there is inter-cluster communication as shown in the two unique 
clusters for the progression group (cluster six and seven). progression-specific 
clusters produce distinct kinds of inflammatory cytokines (figure 8) indicating their 
cooperation to boost the inflammatory process. For instance, cluster six produces the 
cytokine CCL2 and cluster seven expresses the G-protein coupled receptor CCR2, the 
binding partner for CCL2 (figure 11-A). CCL2-CCR2 interaction stimulates signal 
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transduction through CCR2 receptor resulting in overexpression of FN1 in cluster 
seven and fibronectin deposition, which is one of the earliest signs during 
atherosclerosis development. This finding indicates that a small subset of 
macrophages is a source of the deposited fibronectin in the plaque micro-
environment. On the other hand, the regression-specific macrophages (cluster four) 
downregulates CCR2, so that no signal transduction can be stimulated even in the 
presence of CCL2 in the lesion site. Consequently, identification of the possible 
mechanisms of modulating ECM components by macrophages could help in better 
understanding the disease progression. 
5.3 Dendritic Cell Maturation in the Progression Branch 
 Dendritic cells (DCs) during initial stages of atherosclerosis have been found 
to be accumulated dramatically in the plaques (Galkina E et al., 2006). Pathways 
activity analysis reveals that dendritic cell maturation signaling is upregulated in the 
progression branch and not in the regression branch (figure 10-A). In fact, DCs have 
been found to be able to accumulate lipids resulting in disease progression (Paulson 
KE et al., 2010) and produce distinct pro-inflammatory cytokines such as CCL2 and 
CCL4 to further recruit monocytes in the lesion area. (Huang DR et al., 2001; 
Braunersreuther V et al., 2007). Furthermore, CCR2, was found to be positively 
correlated with DCs level in atherosclerotic plaque (Combadiere C et al., 2003; 
Combadiere C et al., 2008; Liu P, 2008) which is higher in progression branch as 
previously mentioned. However, the regression branch has low expression of the 
transmembrane receptor CD74, resulting in inhibiting DCs motility in mice (Faure-
Andre G et al., 2008). Besides, mice lacking CD74 have marked reduction of the 
atherosclerotic plaque development (Sun J et al., 2010). This investigation offers 
 44 
 
insight into a potential role of macrophages on activating and suppressing of dendritic 
cells during atherosclerosis development. 
5.4 Cytokines in Progression and Regression 
 Cytokines in atherosclerotic plaques have both pro-inflammatory and anti-
inflammatory roles (McLaren J E, 2011; Ait-Oufella H, 2011). The results revealed 
upregulation of distinct set of cytokines in each branch. The progression branch 
shows upregulation of CXCL1, CXCL2, CXCL10, CCL3 CCL4, CCL5, CCL7, 
CCL9, CCL12, IL1B, IL6, IL1RN and IFNB1, while the regression branch shows 
upregulation of TSLP, PF4 and CCL24 and downregulation of the progression-
specific cytokines (figure 8). 
 During initial stage of the disease where capturing and rolling of  monocytes 
occurs, CCL5 and CXCL1 interact with proteoglycans and P-selectins on endothelial 
cells causing immobilization (Ley K et al., 2007; Moore K J et al., 2013; Soehnlein O 
et al., 2013). Both genes (CCL5 and CXCL1) have higher RNA expression level in 
the progression branch. Additionally, CCL5 deposition in the plaques promotes 
monocyte arrest (Von Hundelshausen P et al., 2001) and knockout of Y-box binding-
protein 1 which regulates CCL5 expression level results in reduction of neointimal 
formation in ApoE -/- mice models (Krohn R et al., 2007). CXCL10, CCL3, CCL7, 
IFNB1 and IL1-Beta, which are higher in the progression branch, have been found to 
be involved in atherosclerosis progression and their downregulation reduces the pro-
inflammatory genes and atherosclerosis plaque burden (Kirii H et al., 2003; Heller E 
A, 2006; Kennedy A et al., 2012; de Jager S C et al., 2013; Alexander M R et al., 
2012, Denes A et al., 2012; Ting-Ting Chang et al., 2016). Moreover, IL-6 injection 
in ApoE -/- mice increases plaque size and pro-inflammatory cytokines, while its 
inhibition enhances atherosclerosis via reducing plaque size, decreasing activation of 
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endothelial cells and reducing monocytes recruitment (Huber S A et al., 1999, Madan 
M et al., 2008). 
 Furthermore, CCL2 was found to be higher in the progression branch. In 
addition to its role in recruiting leukocytes to the inflammation site, it represses the 
expression of the molecules responsible for cholesterol efflux from the cells resulting 
in impairment of reverse cholesterol transport mechanism (Weber C et al., 2011; 
Huang C X et al., 2013). Additionally, Pro-inflammatory cytokines cause inhibition 
of LXR (Liver X receptors) signaling disrupting cholesterol efflux and resulting in 
foam cell formation. (Pascual-García M et al., 2013). LXR signalling was found to 
have less activity in progression branch and more activity in regression branch from 
the pathway activity analysis (figure 10-A). 
 On the other hand, among the three cytokines found to be upregulated in the 
regression branch, thymic stromal lymphopoietin (TSLP) was found to attenuate 
atherosclerosis development (Kunwu Tu et al., 2013) and to promote macrophages 
polarization towards M2 phenotype (Debin et al., 2019). Additionally, it further 
upregulates CD63 tetraspanin (Wang B et al., 2013) which was also found to be 
secreted in M2 macrophages exosomes (Peiming Zheneg et al., 2018). The second 
cytokine, CCL24, also has been shown to be expressed in M2 phenotypes (Martinez 
FO et al., 2006). The functionality of the third cytokine (PF4) found in the regression 
group awaits further investigation. Taken together, the results indicate the production 
of  anti-inflammatory cytokines from the macrophages in the regression branch 
driving the process of atherosclerosis resolution. 
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5.5 Analysis of the Transcription Regulatory Network 
 5.5.1 Role of STAT1 and IRF7 in Maintaining the Inflammatory Module 
 The progression branch-specific macrophages activate a transcriptional 
program resulted in producing distinct kinds of cytokines and other molecules 
aggravating the inflammatory response in the atherosclerotic plaque lesion site as 
shown in figure 11-B. Together, STAT1 and IRF7 transcription factors upregulate 
multiple pro-inflammatory cytokines such as CXCL10 and CCL12 (Vogel SN et al., 
2003; Miyagawa F et al., 2016) and downregulate the cytokine TSLP which is 
upregulated in the regression-specific macrophages. Moreover, they upregulate the 
expression of three peptidases (PSMB8, PSMB9 and USP18), which play a part in the 
immunoproteasome machinery system in immune cells (figure 13-A, B)  (Barton LF 
et al., 2002; Goubau D et al., 2009). Notably, immunoproteasome is required for 
protein processing to present antigenic peptides on MHC class I molecules (Kloetzel 
PM, 2004) and it was found to be involved in autoimmune diseases pathogenesis 
(Gutcher I et al., 2007). In fact, peptidases upregulation in the progression branch-
specific macrophages sheds light towards their involvement in the continuous 
inflammatory process during atherosclerosis development. 
 Interestingly, STAT1 and IRF7 also upregulates interferon induced proteins 
and IFIT family proteins (Interferon Induced Protein with Tetratricopeptide Repeats) 
as shown in figure 11 and 13-A. IFIT family members were found to be expressed 
during viral infection and following IFN treatment (Diamond et al., 2012). They have 
unique structure as they lack any enzymatic domains or activity. Rather, they have 
multiple copies of TPR motif (tetratricopeptide), whose presence in proteins indicates 
their role in cell cycle regulation, protein folding and protein transport. (D’Andrea LD 
et al., 2003). IFIT proteins role in inflammation has contradicting results. Some 
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studies reported their role in reducing the inflammation (Berchtold S et al., 2008; Li 
Y et al., 2009), while others reported their role in augmenting the inflammatory 
response. (McDermott JE et al., 2012). Recently, IFIT1, IFIT2 and IFIT3 were found 
to be severely upregulated in M1 phenotype macrophages (Huang C et al., 2018), 
indicating their role in inflammatory response. Accordingly, this investigation suggest 
that IFIT family proteins might have a role in atherosclerosis development. In 
addition, IFI35 has been previously identified to have a role in neointimal formation 
and to serve in endothelial cell migration and proliferation (Jian D et al., 2018). 
Moreover, interferon-stimulated exonucleases (ISG15 and ISG20) and IFI44 
upregulation by IRF7 (Lazear HM et al., 2013) in atherosclerosis needs further 
investigation as they show high expression level in progression-specific macrophages 
(figure 13-A). 
 Surprisingly, once the inflammatory module is initiated, distinct feed-forward 
loops and trans-activation patterns between STAT1 and IRF7 have been developed to 
maintain the inflammatory process (Figure 11-B), while inhibiting the expression of 
other cytokines such as TSLP that was found to be upregulated in the regression 
branch-specific macrophages. 
 5.5.2 Interrupting the Inflammatory Module 
 On the contrary, regression branch-specific macrophages interrupt the 
inflammatory network at multiple levels as seen in figure 11-C. Macrophages in the 
regression branch show early downregulation of the transcription factor ID2 
(Inhibitor of DNA binding 2), which has been reported to upregulate IRF5 (Li J et al., 
2017), preventing its downstream upregulation of IRF7, IFNB1 and STAT1 (Lazear 
HM et al., 2013; Steinhagen F et al., 2015). Additionally, upon upregulation of IGF1 
by S1PR1 stimulation (Straub AC et al., 2009), signal transduction through IGF1 
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interrupts the inflammatory network in multiple ways. For instance, IGF1 
downregulates a number of pro-inflammatory cytokines CCL3, IL6 and IL1B as 
shown on figure 11-C (Santini MP et al., 2007; Chand HS et al., 2012). Furthermore, 
IGF1 can downregulate STAT1 downstream targets such as PSMB8 and PSMB9 (the 
immunoproteasome subunits) (Pan Y et al., 2013) indicating their involvement in the 
disease progression (figure 13-B).  
 Likewise, upregulation of IGF1 further results in breaking the inflammatory 
module by decreasing activation of STAT1 and by inhibiting expression of IL6 
(Bernabei P et al., 2003). IL6 inhibition resulted in upregulation of the anti-
inflammatory cytokine TSLP through downregulation of its inhibitor CCR2 (Bromley 
SK et al., 2013). Consequently, TSLP upregulates the expression of the M2 
macrophage surface marker CD63 denoting polarization towards M2 anti-
inflammatory phenotype (Wang B et al., 2013). 
 The analysis of the transcriptional regulatory network offers new insights into 
potential roles of different transcription factors, growth factors and signal 
transduction through G-protein coupled receptors in controlling expression of a wide 
range of genes differentially expressed in macrophages in both branches. 
 5.5.3 Role of MAFB in Atherosclerosis 
 MAFB is a basic leucine zipper transcription factor involved in development 
and lineage-specific hematopoiesis. (Kelly et al., 2000). It has been reported that 
MAFB drives macrophages to M2 anti-inflammatory phenotype by altering various 
number of inflammatory related genes (Víctor D et al., 2017) as shown in figure 14-
A. MAFB upregulates the solute carrier SLC40a1 (Ferroportin-1) which has a role in 
iron efflux from the cells. Indeed, deposition of iron in atherosclerotic lesion occurs 
 49 
 
following intra-plaque haemorrhage (Kolodgie, F D et al., 2003). SLC40a1 was found 
to be downregulated in the macrophages from the progression branch indicating loss 
of their ability to export iron outside the cell. Consequently, overloading with iron 
catalyses reactive oxygen species generation and lipid oxidation in the foam cells, 
which in turn aids in further progression of the disease (Ramakrishna G et al., 2003). 
Additionally, macrophages enriched with CD163 in atherosclerotic plaques were 
found to have less lipid contents and less oxidative damage (Finn et al., 2012). 
 5.6 Role of the predicted miRNAs 
 Ten miRNAs were predicted to be upregulated to cause such alteration in the 
gene expression in the progression branch-specific macrophages as shown in figure 
10-B. Some of them were previously identified to play a role in atherosclerosis 
progression. The role of miRNA-155 in atherosclerosis remains controversial as some 
studies reported that its overexpression in ApoE-/- mice reduces the atherosclerosis 
(Zhu et al., 2012) and others reported that its deficiency reduces the lesion size in 
ApoE-/- mice (Nazari-Jahantigh et al., 2012). Recently, it has been reported that mice 
with ApoE-/- / miR-155-/- double knockout have less atherosclerotic lesion (Anthony 
Virtue et al., 2017). The exact role of miR-155 in atherosclerosis is not clear. The 
results indicate that miR-155 can bind to the 3’ untranslated region of multiple 
mRNAs suppressing the expression of a variety of genes such as LRP1, TGFBR2, 
NRP1 and MAFB (figure 10-C). Mutation of LRP1 (Low-Density Lipoprotein 
Receptor-Related Protein 6) was found to cause a number of metabolic diseases such 
as hyperlipedemia, type 2 diabetes (Mani A. et al 2007). Particularly, LRP6 mutation 
is associated with increase plasma LDL level (Tomaszewski M et al., 2009) which is 
one of the major risk factor of atherosclerosis development. NRP1 (Neuropilin 1) 
deficiency shifts the energy metabolism of macrophages towards glycolysis (Ariel 
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Molly Wilson et al., 2018) as in the M1 phenotype resulting in more lactate and 
reactive-oxygen species production and consequently more inflammation and 
inefficient fatty acids burning (West AP et al., 2011). 
 ABCA1 (ATP Binding Cassette Subfamily A. Member 1) was predicted to be 
targeted with miR-148, miR-140 and miR-758. ABCA1 was previously identified to 
stimulate cholesterol efflux (Wang N et al., 2000, Oram JF et al., 2000). Mutations of 
ABCA1 resulted in increasing cholesterol deposition in cells and tissues, especially in 
macrophages (Assmann et al., 1995) and a significant reduction in plasma HDL level 
(Marcil M et al., 1999). Anti-miR-148a shows reduction in the atherosclerotic plaque 
formation (Rotllan N et al., 2018). MiR-410 inhibition was found to rescue 
endothelial cells apoptosis by regulating oxidized-LDL levels (Ming-Yan Hu et al., 
2018). MiR-758 was identified before to target ABCA1 resulting in suppressing 
cholesterol efflux from the cell (Ramirez CM et al., 2011) 
 IGF1, MAF and MAFB have been identified to be targeted with the predicted 
miRNAs, resulting in suppressing their role in resolving the inflammation in the 
progression-specific macrophages. 
 MiR-129-5p upregulation was suggested to have a protective role in 
atherosclerosis through suppression of endothelial cell autophagy (Zhaohua Geng et 
al., 2016), which was predicted in the results to be upregulated in the progression-
specific macrophages. This contradicting finding needs further validation. 
 The miRNAs prediction results confirmed the previously identified findings 
from the literatures and revealed additional roles of those miRNAs. In addition, the 
results offer new insights on other miRNAs involvement in the disease progression 
such as miR-344-3p, miR-346 and miR-485-5p.  
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CHAPTER 6: CONCLUSION AND FUTURE PERSPECTIVES 
 6.1 Conclusion 
 Atherosclerosis inflammatory sites contain both pro-inflammatory and anti-
inflammatory macrophages. Each subset of macrophage activates unique 
transcriptional program with distinct pathways and metabolic activities. Activating 
integrin signalling and maturation of dendritic cells by the inflammatory macrophages 
aggravates the inflammation by ECM remodelling. Inflammatory macrophages 
express distinct set of genes to activate an inflammatory module aggravating the 
atherosclerosis inflammation and disrupting cholesterol metabolism resulting in 
intracellular cholesterol retention and foam cell differentiation. By upregulating 
certain genes such as STAT1 and IRF7, macrophages can activate various pathways 
to produce inflammatory cytokines which have positive regulatory effects on those 
genes to maintain the inflammatory process. In contrary, upregulation of genes 
responsible for cholesterol efflux and prevention of foam cell formation were found 
in the anti-inflammatory macrophages. In addition, interrupting the inflammatory 
module in M2 macrophages can be achieved by altering expression level of certain 
transcription factors and key genes that act systematically to dampen the 
inflammatory network by interrupting it at various levels. Anti-inflammatory 
macrophages upregulates IGF1 and MAFB and downregulate ID2 transcription 
factor, which in turn interrupt the inflammatory network through downregulating 
STAT1, IRF7, IL6, IL1B and their targets as well. Understanding how anti-
inflammatory macrophages suppress inflammation is a key step to better understand 
atherosclerosis resolution and offers new insights on how to force the transition of 
macrophages from inflammatory phenotype to anti-inflammatory phenotype. 
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 6.2 Future Perspectives 
 This study has some limitations regarding the validation of the detected 
candidates and the techniques used. It is limited to the computational analysis of 
distinct macrophage states during atherosclerosis progression and regression. Future 
work to experimentally validate the candidates is required. Additionally, although 
single cell RNA sequencing allows detection of the heterogeneity among the total 
population, the technique has shallow coverage and not like deep bulk RNA 
sequencing. For instance, the average number of genes detected per cell is ranging 
from 1000 to 2000 genes per cell in this dataset. Also, alternative splicing events are 
difficult to be detected among the clusters because of the low number of reads per 
gene in each cell. It is recommended for future studies to take into consideration 
performing bulk RNA sequencing on cluster-basis. For instance, a combination of 
unique surface markers can be identified for progression-specific clusters (cluster six 
and seven) and the regression-specific one (cluster four) for sorting them and 
performing deep RNA sequencing. This will extend the network analysis to include 
more candidates and pathways that may be identified as therapeutic targets. 
Furthermore, understanding how macrophages gradually change their states from 
inflammatory to anti-inflammatory phenotypes can be used to force them to enter 
anti-inflammatory state.  Future research and experimental validations are required 
using atherosclerotic mice models to confirm the findings.  
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